Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.0B | 6.6B | 6.4B | 6.5B |
Cost of revenue | 3.9B | 4.3B | 4.2B | 4.2B |
Gross profit | 2.1B | 2.2B | 2.2B | 2.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 837M | 869M | 821M | 885M |
Other operating expenses | — | — | — | — |
Operating income | 1.2B | 1.4B | 1.4B | 1.4B |
Non operating interest income | ||||
Income | 23M | 20M | 16M | 17M |
Expense | 229M | 227M | 230M | 229M |
Other income expense | -3M | -1.4B | -1.4B | -849M |
Pretax income | 1.0B | -238M | -283M | 348M |
Tax provision | 304M | -2.4B | 7M | 248M |
Net income | 714M | 2.1B | -290M | 100M |
Basic EPS | 0.6 | 1.8 | -0.2 | 0.1 |
Diluted EPS | 0.6 | 1.8 | -0.2 | 0.1 |
Basic average shares | 1.2B | 1.2B | 1.2B | 1.2B |
Diluted average shares | 1.2B | 1.2B | 1.2B | 1.2B |
EBITDA | 1.5B | 1.6B | 1.6B | 1.7B |
Net income from continuing op. | 714M | 2.1B | -290M | 100M |
Minority interests | -2M | -1M | 0 | 2M |
Preferred stock dividends | — | — | — | — |